GLS and hepatocellular carcinoma: Data from the TCGA database reveal overexpression of GLS1 in various solid tumors, including stomach adenocarcinoma, head and neck squamous cell carcinoma, thymoma, testicular germ cell tumors, HCC, colon adenocarcinoma, and others.